PharmAla Biotech Holdings, Inc.'s total assets for Q1 2026 were C$3.40M, a decrease of -0.61% from the previous quarter. TSE:MDMA total liabilities were C$1.03M for the fiscal quarter, a 6.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.